These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2228396)

  • 1. The effect of long-term dexfenfluramine treatment on 24-hour energy expenditure in man. A double-blind placebo controlled study.
    Breum L; Astrup A; Andersen T; Lammert O; Nielsen E; Garby L; Quaade F
    Int J Obes; 1990 Jul; 14(7):613-21. PubMed ID: 2228396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dexfenfluramine on energy expenditure in obese patients on a very-low-calorie-diet.
    Recasens MA; Barenys M; Sola R; Blanch S; Masana L; Salas-Salvadó J
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):162-8. PubMed ID: 7780491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
    Lafreniere F; Lambert J; Rasio E; Serri O
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):25-30. PubMed ID: 8383638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dexfenfluramine on resting metabolic rate and thermogenesis in premenopausal obese women during therapeutic weight reduction.
    Van Gaal LF; Vansant GA; Steijaert MC; De Leeuw IH
    Metabolism; 1995 Feb; 44(2 Suppl 2):42-5. PubMed ID: 7869937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effect of dexfenfluramine on resting metabolic rate and postprandial thermogenesis in obese subjects: a double-blind placebo-controlled study.
    Scalfi L; D'Arrigo E; Carandente V; Coltorti A; Contaldo F
    Int J Obes Relat Metab Disord; 1993 Feb; 17(2):91-6. PubMed ID: 8384170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.
    Swinburn BA; Carmichael HE; Wilson MR
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1033-40. PubMed ID: 8923161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dexfenfluramine on energy expenditure in man.
    Schutz Y; Munger R; Dériaz O; Jéquier E
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S61-6. PubMed ID: 1338324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of dexfenfluramine on amino acid profiles and food selection in obese patients during weight loss.
    Breum L; Møller SE; Andersen T; Astrup A
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):147-53. PubMed ID: 8646251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a novel beta-adrenoceptor agonist (Ro 40-2148) on resting energy expenditure in obese women.
    Haesler E; Golay A; Güzelhan C; Schutz Y; Hartmann D; Jéquier E; Felber JP
    Int J Obes Relat Metab Disord; 1994 May; 18(5):313-22. PubMed ID: 7914795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans.
    Fogteloo AJ; Pijl H; Frölich M; McCamish M; Meinders AE
    Diabetes Nutr Metab; 2003 Apr; 16(2):109-14. PubMed ID: 12846450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity.
    Ditschuneit HH; Flechtner-Mors M; Dolderer M; Fulda U; Ditschuneit H
    Horm Metab Res; 1993 Nov; 25(11):573-8. PubMed ID: 8288160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of oils containing triacylglycerols and medium-chain fatty acids in the dietary treatment of obesity. The effect on resting energy expenditure and serum lipids].
    Hainer V; Kunesová M; Stich V; Zák A; Parizková J
    Cas Lek Cesk; 1994 Jun; 133(12):373-5. PubMed ID: 8069895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged surveillance of dexfenfluramine in severe obesity.
    Mathus-Vliegen EM
    Neth J Med; 1993 Dec; 43(5-6):246-53. PubMed ID: 8107932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a thermogenic beverage on 24-hour energy metabolism in humans.
    Rudelle S; Ferruzzi MG; Cristiani I; Moulin J; Macé K; Acheson KJ; Tappy L
    Obesity (Silver Spring); 2007 Feb; 15(2):349-55. PubMed ID: 17299107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dl-fenfluramine on thermic effect of food in humans.
    Troiano RP; Levitsky DA; Kalkwarf HJ
    Int J Obes; 1990 Aug; 14(8):647-55. PubMed ID: 2228399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observations on the treatment of obese patients with dexfenfluramine].
    Cairella M; Pisculli M; Petraroli AR; Riganelli S; Saracino A; Siani V
    Clin Ter; 1990 Jun; 133(5):289-97. PubMed ID: 2143712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term changes of body weight and cardiovascular risk factors after weight reduction with group therapy and dexfenfluramine.
    Pfohl M; Luft D; Blomberg I; Schmülling RM
    Int J Obes Relat Metab Disord; 1994 Jun; 18(6):391-5. PubMed ID: 8081430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dexfenfluramine on body weight, blood pressure, insulin resistance and serum cholesterol in obese individuals.
    Holdaway IM; Wallace E; Westbrooke L; Gamble G
    Int J Obes Relat Metab Disord; 1995 Oct; 19(10):749-51. PubMed ID: 8589769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.